Capricor Therapeutics Inc (CAPR)

SG&A Expense Growth

54.00%

Quarterly · Period ending:

CAPR logo

CAPR SG&A Expense Growth

Latest reported54.00%
CAPR Quarterly SG&A Growth (QoQ) (0.00% → 54.00%)
High-resolution chart · PNG

CAPR sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Capricor Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-34.4501%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.